COA
Certificate of Analysis
Third-party HPLC and MS testing for every batch, published before purchase and tied to the batch being sold.
HPLC / MSVR-RT
Metabolic Research
VR-RT10mg
Triple-receptor agonist (GLP-1 / GIP / Glucagon).
$89per vial
Product handling note
Lyophilized powder may shift or come loose during transit; that is a normal occurrence and does not affect the integrity of the research product. Fill appearance and batch-specific details may vary. Refer to the Certificate of Analysis below for the documentation tied to the current batch.
Research overview
Why researchers study triple-agonist peptides.
VR-RT belongs to a newer category of research peptides built around three metabolic signaling systems: GLP-1, GIP, and glucagon. In plain English, researchers are asking what changes when one molecule is designed to interact with all three instead of just one or two.
That makes it an interesting model for comparing how these pathways behave, how they overlap, and how triple-agonist designs differ from single- or dual-pathway peptides.
The receipts
What you get with every vial.
ID
Batch traceability
Every vial is stamped with a batch ID that links back to its COA, source record, and current product documentation.
Batch linkedLabel
Batch-linked labeling
Product identity, strength, and batch reference stay easy to match from the product listing to the vial in hand.
Listing to vialRelated peptides
Adjacent research lanes.
Product FAQ
Common research questions.
What is the glucagon lane adding to the research picture?
GLP-1 and GIP are usually discussed through incretin signaling. The glucagon-receptor lane adds a different metabolic signal to study, especially around hepatic glucose handling, lipid metabolism, and energy-balance models.
Why compare VR-RT against VR-TZ?
VR-TZ is the cleaner two-pathway comparison. VR-RT adds glucagon-receptor activity, so the useful question is not just "which is stronger" but what changes when a third receptor system is added to the model.
What would make a VR-RT batch record worth trusting?
The batch page should tie the vial code to identity testing, purity testing, the lab report date, and the exact lot being shipped. If the batch code on the vial misses the published COA, the documentation misses the point.
Should VR-RT be compared by dose, price, or receptor profile?
Start with receptor profile. Dose tells you vial strength, price tells you catalog position, but the real research distinction is the GLP-1 / GIP / glucagon receptor map and the batch documentation behind the material.
Research sources
Literature links are included for background reading. Batch-specific identity and purity details live in the COA tied to the current batch.